- Discover
- /
- PTPI
Sagehood
Financial Analyst
PREMIUM
Technical Trader
PREMIUM
Valuation Projection
PREMIUM
Social Media Buzz
PREMIUM
News Agent
PREMIUM
Macro Economist
PREMIUM
About PTPI
9/15/2025
Comprehensive Analysis
Financial Health
- Balance Sheet: Petros Pharmaceuticals (PTPI) is insolvent, with liabilities ($18.1M) exceeding assets ($10.6M) and negative equity (-$7.47M). The current ratio (0.40) and quick ratio (0.23) indicate severe liquidity strain, with insufficient current assets to cover short-term obligations.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
- View 5 tickers daily
- Create and manage Watchlists
- Import portfolios (no personalized insights)
- Chat with the general Sagehood AI Agent
- Market Radar: Preview access only
Premium Membership
- Unlimited AI-generated insights across all sections
- Market Overview
- Market Radar (AI-driven investment opportunities)
- Access to all Sagehood AI agents, including domain-specific experts
- Personalized insights and actionable recommendations for smarter investing